Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma
Open Access
- 10 November 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Abstract
Metabolic reprogramming evolves during cancer initiation and progression. However, thorough understanding of metabolic evolution from preneoplasia to lung adenocarcinoma (LUAD) is still limited. Here, we perform large-scale targeted metabolomics on resected lesions and plasma obtained from invasive LUAD and its precursors, and decipher the metabolic trajectories from atypical adenomatous hyperplasia (AAH) to adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC), revealing that perturbed metabolic pathways emerge early in premalignant lesions. Furthermore, three panels of plasma metabolites are identified as non-invasive predictive biomarkers to distinguish IAC and its precursors with benign diseases. Strikingly, metabolomics clustering defines three metabolic subtypes of IAC patients with distinct clinical characteristics. We identify correlation between aberrant bile acid metabolism in subtype III with poor clinical features and demonstrate dysregulated bile acid metabolism promotes migration of LUAD, which could be exploited as potential targetable vulnerability and for stratifying patients. Collectively, the comprehensive landscape of the metabolic evolution along the development of LUAD will improve early detection and provide impactful therapeutic strategies.Keywords
Funding Information
- National Natural Science Foundation of China (92057209)
This publication has 66 references indexed in Scilit:
- Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionJournal of Clinical Investigation, 2013
- Serine, glycine and one-carbon units: cancer metabolism in full circleNature Reviews Cancer, 2013
- Results of Initial Low-Dose Computed Tomographic Screening for Lung CancerNew England Journal of Medicine, 2013
- Specific bile acids inhibit hepatic fatty acid uptake in miceHepatology, 2012
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue TypeCell Metabolism, 2012
- Glycerophospholipid Synthesis as a Novel Drug Target Against CancerCurrent Molecular Pharmacology, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Large-Scale Human Metabolomics Studies: A Strategy for Data (Pre-) Processing and ValidationAnalytical Chemistry, 2005